Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Cancer Care (Engl) ; 19(2): 276-8, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19708932

RESUMEN

The finding of three primary gynaecological malignancies in a young woman attending our unit was documented in 2001. We provide an update on this report as new events have prompted further discussion on the role of clinical guidelines in cancer management. The discovery of a genetic predisposition demonstrates the need for multidisciplinary input and heightened awareness in similar cases while the importance of treating each patient as an individual is emphasized.


Asunto(s)
Neoplasias de la Mama/genética , Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Predisposición Genética a la Enfermedad/genética , Neoplasias de los Genitales Femeninos/genética , Neoplasias Primarias Múltiples/genética , Adulto , Neoplasias de la Mama/cirugía , Neoplasias Colorrectales Hereditarias sin Poliposis/cirugía , Femenino , Humanos , Resultado del Tratamiento
2.
Scott Med J ; 54(2): 21-3, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19530497

RESUMEN

BACKGROUND AND AIMS: The Scottish Intercollegiate Guidelines Network (SIGN) recommends the use of the Risk of Malignancy Index (RMI) for ovarian tumours, a scoring system based on ultrasound findings, menopausal status and CA 125 level, in the pre-operative evaluation of pelvic masses. The aim of this study was to investigate the accuracy of this as a predictive method of discriminating benign from malignant disease. METHODS AND RESULTS: All women who underwent oophorectomy in 2004 at Aberdeen Royal Infirmary for suspected primary ovarian pathology were evaluated. The RMI was calculated and these results were compared with the final histopathology. The sensitivity of the RMI for diagnosing malignant ovarian disease was 94% (32/34) while the specificity was 70% (76/108). CONCLUSIONS: Compared to previous studies, the RMI score was highly sensitive in detecting malignant disease, although not as specific in excluding benign lesions, particularly cystadenomas and endometriomas. This can be improved by the refinement of imaging techniques as well as the use of laparoscopy in particular cases. The RMI score may also be especially valuable in directing referrals to a specialised centre.


Asunto(s)
Indicadores de Salud , Neoplasias Ováricas/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Antígeno Ca-125/sangre , Estudios de Cohortes , Femenino , Humanos , Menopausia , Persona de Mediana Edad , Neoplasias Ováricas/etiología , Neoplasias Ováricas/cirugía , Ovariectomía , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Estudios Retrospectivos , Medición de Riesgo , Escocia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA